Capital World Investors 13D/13G Filings for Rubius Therapeutics, Inc. (RUBY)

Capital World Investors 13D and 13G filings for Rubius Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
1:00 pm
Sale
2021-02-1613GRubius Therapeutics, Inc.
RUBY
Capital World Investors1,117,000
1.400%
-4,060,000decrease
(-78.42%)
Filing
2020-02-14
2:19 pm
Purchase
2019-12-3113GRubius Therapeutics, Inc.
RUBY
Capital World Investors5,177,000
6.400%
5,177,000increase
(New Position)
Filing